In ₹ Crore except Per Share Latest Annual | RUBICON FY26 | SHILPAMED FY26 | SPARC FY26 | STAR FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 115.40× | 75.80× | ◆ 4.11× | 20.07× | 20.07× +475% | |
| P/B | 22.94× | 7.12× | 4.77× | ◆ 3.54× | 4.77× +381% | |
| EV/EBITDA | 74.06× | 43.85× | ◆ 4.34× | 13.66× | 13.66× +442% | |
| Market Cap | ₹29,568 Cr | ₹18,445 Cr | ₹6,386 Cr | ₹11,162 Cr | ₹11,162 Cr +165% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 13.59% | ◆ 95.98% | 9.62% | 13.59% | |
| Revenue CAGR 5Y | — | ◆ 11.30% | — | 7.94% | 9.62% | |
| Revenue YoY (latest Q) | — | 44.90% | ◆ 314.11% | 13.01% | 44.90% | |
| Net Income YoY (latest Q) | — | ◆ 115.16% | 59.94% | 56.73% | 59.94% | |
| Profitability | ||||||
| EBITDA Margin | 22.82% | 28.25% | ◆ 85.08% | 19.04% | 28.25% -19% | |
| Net Income Margin | 14.07% | 15.81% | ◆ 82.65% | 11.82% | 15.81% -11% | |
| Return on Common Equity | 19.14% | 9.39% | ◆ 116.20% | 17.66% | 17.66% +8% | |
| Return on Capital Employed | 23.81% | 11.02% | ◆ 112.12% | 17.93% | 17.93% +33% | |
| Return on Assets | 10.60% | 6.57% | ◆ 71.55% | 8.29% | 8.29% +28% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.20× | 0.25× | 0.42× | 0.53× | 0.42× -52% | |
| Interest Coverage | 8.42× | 5.36× | ◆ 46.54× | 4.05× | 5.36× +57% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,754 Cr | ₹1,539 Cr | ₹1,879 Cr | ₹4,859 Cr | ₹1,879 Cr -7% | |
| Net Income | ₹247 Cr | ₹243 Cr | ₹1,553 Cr | ₹575 Cr | ₹575 Cr -57% | |
| Total Assets | ₹2,327 Cr | ₹3,706 Cr | ₹2,171 Cr | ₹6,927 Cr | ₹3,706 Cr -37% | |
| EPS | ₹15.52 | ₹12.44 | ₹47.86 | ₹60.34 | ₹47.86 -68% | |
| Book Value per Share | ₹78.07 | ₹132.47 | ₹41.26 | ₹341.68 | ₹132.47 -41% | |